You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NRIX Sale Disclosure
Hansen Gwenn · SEC Form 4 · Filed Aug 5, 2026
Sale
Calculated transaction value
$108.9K
Hansen Gwenn Chief Scientific Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Aug 5, 2026
Public filing date
Aug 5, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$25.12
Aug 5, 2026
First close after public filing
$25.22
Aug 6, 2026
30-day return after filing
+3.65%
Through Sep 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,356 shares @ $25
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817160-26-000017
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$117K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX Current | Sale | Aug 5, 2026 | $108.9K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Aug 5, 2026 | $0 |
| Nurix Therapeutics, Inc. NRIX | Exercise | Aug 5, 2026 | $8.1K |